nodes	percent_of_prediction	percent_of_DWPC	metapath
Lithium—Electrocardiogram change—Teniposide—lymphatic system cancer	0.0514	0.0514	CcSEcCtD
Lithium—Optic atrophy—Vincristine—lymphatic system cancer	0.0412	0.0412	CcSEcCtD
Lithium—Skin ulcer—Mechlorethamine—lymphatic system cancer	0.0256	0.0256	CcSEcCtD
Lithium—Blindness—Fludarabine—lymphatic system cancer	0.0233	0.0233	CcSEcCtD
Lithium—Oliguria—Mechlorethamine—lymphatic system cancer	0.0216	0.0216	CcSEcCtD
Lithium—Optic neuritis—Fludarabine—lymphatic system cancer	0.021	0.021	CcSEcCtD
Lithium—Intracranial pressure increased—Carmustine—lymphatic system cancer	0.0198	0.0198	CcSEcCtD
Lithium—Blindness—Vincristine—lymphatic system cancer	0.0142	0.0142	CcSEcCtD
Lithium—Taste metallic—Methotrexate—lymphatic system cancer	0.012	0.012	CcSEcCtD
Lithium—Coma—Fludarabine—lymphatic system cancer	0.0118	0.0118	CcSEcCtD
Lithium—Stupor—Carmustine—lymphatic system cancer	0.0111	0.0111	CcSEcCtD
Lithium—Nystagmus—Vincristine—lymphatic system cancer	0.011	0.011	CcSEcCtD
Lithium—Scotoma—Carmustine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Lithium—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00933	0.00933	CcSEcCtD
Lithium—Alopecia—Mechlorethamine—lymphatic system cancer	0.00884	0.00884	CcSEcCtD
Lithium—Leukocytosis—Carmustine—lymphatic system cancer	0.00879	0.00879	CcSEcCtD
Lithium—Dehydration—Fludarabine—lymphatic system cancer	0.00872	0.00872	CcSEcCtD
Lithium—Coordination abnormal—Carmustine—lymphatic system cancer	0.00842	0.00842	CcSEcCtD
Lithium—Depressed level of consciousness—Carmustine—lymphatic system cancer	0.00798	0.00798	CcSEcCtD
Lithium—Urinary incontinence—Carmustine—lymphatic system cancer	0.00798	0.00798	CcSEcCtD
Lithium—Vertigo—Mechlorethamine—lymphatic system cancer	0.00783	0.00783	CcSEcCtD
Lithium—Coma—Carmustine—lymphatic system cancer	0.00755	0.00755	CcSEcCtD
Lithium—Hyperglycaemia—Fludarabine—lymphatic system cancer	0.00731	0.00731	CcSEcCtD
Lithium—Coma—Vincristine—lymphatic system cancer	0.00721	0.00721	CcSEcCtD
Lithium—Urine output increased—Vincristine—lymphatic system cancer	0.00713	0.00713	CcSEcCtD
Lithium—Swelling—Carmustine—lymphatic system cancer	0.0068	0.0068	CcSEcCtD
Lithium—Anorexia—Mechlorethamine—lymphatic system cancer	0.00678	0.00678	CcSEcCtD
Lithium—Arrhythmia—Teniposide—lymphatic system cancer	0.00659	0.00659	CcSEcCtD
Lithium—Polyuria—Vincristine—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Lithium—Alopecia—Teniposide—lymphatic system cancer	0.00652	0.00652	CcSEcCtD
Lithium—Swelling—Mitoxantrone—lymphatic system cancer	0.00632	0.00632	CcSEcCtD
Lithium—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00618	0.00618	CcSEcCtD
Lithium—Folliculitis—Methotrexate—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Lithium—Psoriasis—Methotrexate—lymphatic system cancer	0.00609	0.00609	CcSEcCtD
Lithium—Agitation—Teniposide—lymphatic system cancer	0.0059	0.0059	CcSEcCtD
Lithium—Arrhythmia—Fludarabine—lymphatic system cancer	0.00579	0.00579	CcSEcCtD
Lithium—Alopecia—Fludarabine—lymphatic system cancer	0.00573	0.00573	CcSEcCtD
Lithium—Ataxia—Carmustine—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Lithium—Ataxia—Vincristine—lymphatic system cancer	0.00538	0.00538	CcSEcCtD
Lithium—Weight decreased—Bleomycin—lymphatic system cancer	0.00537	0.00537	CcSEcCtD
Lithium—Dehydration—Vincristine—lymphatic system cancer	0.00533	0.00533	CcSEcCtD
Lithium—Muscular weakness—Carmustine—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Lithium—Confusional state—Teniposide—lymphatic system cancer	0.00529	0.00529	CcSEcCtD
Lithium—Oedema—Teniposide—lymphatic system cancer	0.00524	0.00524	CcSEcCtD
Lithium—Agitation—Fludarabine—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Lithium—Dehydration—Mitoxantrone—lymphatic system cancer	0.00519	0.00519	CcSEcCtD
Lithium—Stupor—Methotrexate—lymphatic system cancer	0.00513	0.00513	CcSEcCtD
Lithium—Muscular weakness—Vincristine—lymphatic system cancer	0.00505	0.00505	CcSEcCtD
Lithium—Anorexia—Teniposide—lymphatic system cancer	0.005	0.005	CcSEcCtD
Lithium—Skin ulcer—Methotrexate—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Lithium—Hypotension—Teniposide—lymphatic system cancer	0.0049	0.0049	CcSEcCtD
Lithium—Convulsion—Fludarabine—lymphatic system cancer	0.00489	0.00489	CcSEcCtD
Lithium—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00486	0.00486	CcSEcCtD
Lithium—Arthralgia—Fludarabine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Lithium—Discomfort—Fludarabine—lymphatic system cancer	0.00475	0.00475	CcSEcCtD
Lithium—Hyperglycaemia—Carmustine—lymphatic system cancer	0.00468	0.00468	CcSEcCtD
Lithium—Confusional state—Fludarabine—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Lithium—Oedema—Fludarabine—lymphatic system cancer	0.00461	0.00461	CcSEcCtD
Lithium—Erectile dysfunction—Vincristine—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Lithium—Decreased appetite—Teniposide—lymphatic system cancer	0.00456	0.00456	CcSEcCtD
Lithium—Vomiting—Mechlorethamine—lymphatic system cancer	0.00452	0.00452	CcSEcCtD
Lithium—Rash—Mechlorethamine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Lithium—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Lithium—Weight decreased—Vincristine—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Lithium—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00444	0.00444	CcSEcCtD
Lithium—Anorexia—Fludarabine—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Lithium—Weight increased—Mitoxantrone—lymphatic system cancer	0.00439	0.00439	CcSEcCtD
Lithium—Weight decreased—Mitoxantrone—lymphatic system cancer	0.00436	0.00436	CcSEcCtD
Lithium—Hyperglycaemia—Mitoxantrone—lymphatic system cancer	0.00435	0.00435	CcSEcCtD
Lithium—Feeling abnormal—Teniposide—lymphatic system cancer	0.00432	0.00432	CcSEcCtD
Lithium—Drowsiness—Mitoxantrone—lymphatic system cancer	0.0043	0.0043	CcSEcCtD
Lithium—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00429	0.00429	CcSEcCtD
Lithium—Nausea—Mechlorethamine—lymphatic system cancer	0.00422	0.00422	CcSEcCtD
Lithium—Alopecia—Bleomycin—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Lithium—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Lithium—Oliguria—Methotrexate—lymphatic system cancer	0.00415	0.00415	CcSEcCtD
Lithium—Abdominal pain—Teniposide—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Lithium—Body temperature increased—Teniposide—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Lithium—Hallucination—Carmustine—lymphatic system cancer	0.00413	0.00413	CcSEcCtD
Lithium—Dyspepsia—Fludarabine—lymphatic system cancer	0.00406	0.00406	CcSEcCtD
Lithium—Dysarthria—Methotrexate—lymphatic system cancer	0.00405	0.00405	CcSEcCtD
Lithium—Decreased appetite—Fludarabine—lymphatic system cancer	0.004	0.004	CcSEcCtD
Lithium—Fatigue—Fludarabine—lymphatic system cancer	0.00397	0.00397	CcSEcCtD
Lithium—Hallucination—Vincristine—lymphatic system cancer	0.00394	0.00394	CcSEcCtD
Lithium—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Lithium—Feeling abnormal—Fludarabine—lymphatic system cancer	0.0038	0.0038	CcSEcCtD
Lithium—Asthenia—Teniposide—lymphatic system cancer	0.00376	0.00376	CcSEcCtD
Lithium—Arrhythmia—Carmustine—lymphatic system cancer	0.00371	0.00371	CcSEcCtD
Lithium—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.0037	0.0037	CcSEcCtD
Lithium—Alopecia—Carmustine—lymphatic system cancer	0.00367	0.00367	CcSEcCtD
Lithium—Body temperature increased—Fludarabine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Lithium—Diarrhoea—Teniposide—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Lithium—Alopecia—Vincristine—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Lithium—Coma—Methotrexate—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Lithium—Discomfort—Bleomycin—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Lithium—Urine output increased—Methotrexate—lymphatic system cancer	0.00346	0.00346	CcSEcCtD
Lithium—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Lithium—Alopecia—Mitoxantrone—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Lithium—Confusional state—Bleomycin—lymphatic system cancer	0.00341	0.00341	CcSEcCtD
Lithium—Vision blurred—Carmustine—lymphatic system cancer	0.0034	0.0034	CcSEcCtD
Lithium—Tremor—Carmustine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Lithium—Oedema—Bleomycin—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Lithium—Vomiting—Teniposide—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Lithium—Agitation—Carmustine—lymphatic system cancer	0.00332	0.00332	CcSEcCtD
Lithium—Asthenia—Fludarabine—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Lithium—Rash—Teniposide—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Lithium—Dermatitis—Teniposide—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Lithium—Dysgeusia—Mitoxantrone—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Lithium—Headache—Teniposide—lymphatic system cancer	0.00328	0.00328	CcSEcCtD
Lithium—Anorexia—Bleomycin—lymphatic system cancer	0.00322	0.00322	CcSEcCtD
Lithium—Agitation—Vincristine—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Lithium—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00317	0.00317	CcSEcCtD
Lithium—Polyuria—Methotrexate—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Lithium—Hypotension—Bleomycin—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Lithium—Diarrhoea—Fludarabine—lymphatic system cancer	0.00315	0.00315	CcSEcCtD
Lithium—Convulsion—Carmustine—lymphatic system cancer	0.00313	0.00313	CcSEcCtD
Lithium—Nausea—Teniposide—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Lithium—Vertigo—Vincristine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Lithium—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Lithium—Convulsion—Vincristine—lymphatic system cancer	0.00299	0.00299	CcSEcCtD
Lithium—Confusional state—Carmustine—lymphatic system cancer	0.00297	0.00297	CcSEcCtD
Lithium—Oedema—Carmustine—lymphatic system cancer	0.00295	0.00295	CcSEcCtD
Lithium—Decreased appetite—Bleomycin—lymphatic system cancer	0.00294	0.00294	CcSEcCtD
Lithium—Vomiting—Fludarabine—lymphatic system cancer	0.00293	0.00293	CcSEcCtD
Lithium—Convulsion—Mitoxantrone—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Lithium—Rash—Fludarabine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Lithium—Dermatitis—Fludarabine—lymphatic system cancer	0.0029	0.0029	CcSEcCtD
Lithium—Headache—Fludarabine—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Lithium—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00286	0.00286	CcSEcCtD
Lithium—Lethargy—Methotrexate—lymphatic system cancer	0.00284	0.00284	CcSEcCtD
Lithium—Discomfort—Mitoxantrone—lymphatic system cancer	0.00283	0.00283	CcSEcCtD
Lithium—Oedema—Vincristine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Lithium—Anorexia—Carmustine—lymphatic system cancer	0.00281	0.00281	CcSEcCtD
Lithium—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Lithium—Confusional state—Mitoxantrone—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Lithium—Hypotension—Carmustine—lymphatic system cancer	0.00276	0.00276	CcSEcCtD
Lithium—Oedema—Mitoxantrone—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Lithium—Nausea—Fludarabine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Lithium—Shock—Mitoxantrone—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Lithium—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Lithium—Anorexia—Vincristine—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Lithium—Body temperature increased—Bleomycin—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Lithium—Hypotension—Vincristine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Lithium—Somnolence—Carmustine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Lithium—Anorexia—Mitoxantrone—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Lithium—Ataxia—Methotrexate—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Lithium—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Lithium—Decreased appetite—Carmustine—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Lithium—Hypotension—Mitoxantrone—lymphatic system cancer	0.00256	0.00256	CcSEcCtD
Lithium—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Lithium—Decreased appetite—Vincristine—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Lithium—Somnolence—Mitoxantrone—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Lithium—Feeling abnormal—Carmustine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Lithium—Fatigue—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Lithium—Asthenia—Bleomycin—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Lithium—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Lithium—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Lithium—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Lithium—Fatigue—Mitoxantrone—lymphatic system cancer	0.00236	0.00236	CcSEcCtD
Lithium—Abdominal pain—Carmustine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Lithium—Body temperature increased—Carmustine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Lithium—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Lithium—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00226	0.00226	CcSEcCtD
Lithium—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Lithium—Body temperature increased—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Lithium—Abdominal pain—Vincristine—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Lithium—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00221	0.00221	CcSEcCtD
Lithium—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Lithium—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Lithium—Vomiting—Bleomycin—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Lithium—Drowsiness—Methotrexate—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Lithium—Rash—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Lithium—Dermatitis—Bleomycin—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Lithium—Asthenia—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Lithium—Asthenia—Vincristine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Lithium—Diarrhoea—Carmustine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Lithium—Nausea—Bleomycin—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Lithium—Asthenia—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Lithium—Dizziness—Carmustine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Lithium—Diarrhoea—Vincristine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Lithium—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Lithium—Vomiting—Carmustine—lymphatic system cancer	0.00187	0.00187	CcSEcCtD
Lithium—Dizziness—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Lithium—Rash—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Lithium—Dermatitis—Carmustine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Lithium—Headache—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Lithium—Tinnitus—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Lithium—Vomiting—Vincristine—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Lithium—Rash—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Lithium—Dermatitis—Vincristine—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Lithium—Headache—Vincristine—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Lithium—Nausea—Carmustine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Lithium—Vomiting—Mitoxantrone—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Lithium—Rash—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Lithium—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Lithium—Headache—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Lithium—Alopecia—Methotrexate—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Lithium—Nausea—Vincristine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Lithium—Dysgeusia—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Lithium—Nausea—Mitoxantrone—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Lithium—Vision blurred—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Lithium—Vertigo—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Lithium—Convulsion—Methotrexate—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Lithium—Arthralgia—Methotrexate—lymphatic system cancer	0.00142	0.00142	CcSEcCtD
Lithium—Discomfort—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Lithium—Confusional state—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Lithium—Anorexia—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Lithium—Hypotension—Methotrexate—lymphatic system cancer	0.00128	0.00128	CcSEcCtD
Lithium—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00124	0.00124	CcSEcCtD
Lithium—Somnolence—Methotrexate—lymphatic system cancer	0.00121	0.00121	CcSEcCtD
Lithium—Dyspepsia—Methotrexate—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Lithium—Decreased appetite—Methotrexate—lymphatic system cancer	0.00119	0.00119	CcSEcCtD
Lithium—Fatigue—Methotrexate—lymphatic system cancer	0.00118	0.00118	CcSEcCtD
Lithium—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Lithium—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Lithium—Abdominal pain—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Lithium—Body temperature increased—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Lithium—Asthenia—Methotrexate—lymphatic system cancer	0.00098	0.00098	CcSEcCtD
Lithium—Diarrhoea—Methotrexate—lymphatic system cancer	0.000934	0.000934	CcSEcCtD
Lithium—Dizziness—Methotrexate—lymphatic system cancer	0.000903	0.000903	CcSEcCtD
Lithium—Vomiting—Methotrexate—lymphatic system cancer	0.000868	0.000868	CcSEcCtD
Lithium—Rash—Methotrexate—lymphatic system cancer	0.000861	0.000861	CcSEcCtD
Lithium—Dermatitis—Methotrexate—lymphatic system cancer	0.00086	0.00086	CcSEcCtD
Lithium—Headache—Methotrexate—lymphatic system cancer	0.000856	0.000856	CcSEcCtD
Lithium—Nausea—Methotrexate—lymphatic system cancer	0.000811	0.000811	CcSEcCtD
